Usually, ovarian cancer develops asymptomatically. Nearly 30%-40% of the newly-diagnosed cases are already at III-IV stage of FIGO. In such patients, there are metastases on the peritoneum of the whole abdominal cavity. The survival rate of the patients with advanced ovarian cancer directly depends on the residual tumour after surgery. This review considers the place and role of cytoreductive surgery in the treatment of advanced ovarian carcinoma.
Scripta Scientifica Medica 2012; 44(2): 11-13.
Email this article (Login required) 
